label: aminopterin/methotrexate embryofetopathy
label_lc: aminopterin/methotrexate embryofetopathy
description: Aminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.